MedTrace Logo

POX Range and the Threshold for Screening Major CHD in Neonates at Different Altitudes

NCT04238104 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2200

Last updated 2021-07-28

No results posted yet for this study

Summary

major CHD (Congenital Heart Disease) screening by POX (pulse oximetry) in sea-level areas is not fit for low, medium and high altitude areas, but the normal range of pulse oximetry at different altitude areas has not been studied before, so the current screening technology can only be used in sea-level areas, but not for newborns in low, medium and high altitude areas. We need to carry out a research to clarify the range of POX and make sure the threshold of POX in major CHD screening in different altitude areas of China.

Conditions

  • POX Range of Healthy Newborns at Different Altitudes
  • POX Threshold for Screening Major CHD in Neonates

Interventions

OTHER

no intervention

it's only observational study. No interventions.

Sponsors & Collaborators

  • Hainan women and children medical center

    collaborator UNKNOWN

  • People's Hospital of Xinjiang Uygur Autonomous Region

    collaborator OTHER

  • Yan'an Affiliated Hospital of Kunming Medical University

    collaborator OTHER

  • Qinghai Red Cross Hospital

    collaborator OTHER

  • Tibet Autonomous Region People's Hospital

    collaborator OTHER

  • People's Hospital of Golog Tibetan Autonomous Prefecture

    collaborator UNKNOWN

  • People's Hospital of Naqu District, Tibet

    collaborator UNKNOWN

  • People's Hospital of Luchun County, Yunnan Province

    collaborator UNKNOWN

  • Children's Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Weili Yan, PhD · Epidemiology Office of Children's hospital of Fudan University

Eligibility

Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2021-04-15
Completion
2021-04-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04238104 on ClinicalTrials.gov